Intelligence Platform

Patents

Browse 416 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7750121

Antibody to telomerase reverse transcriptive

The Regents of the University of Colorado · Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7736652

Antibody fusion proteins: effective adjuvants of protein vaccination

The Regents of the University of California · Granted Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7737256

Antibody against uPA/uPAR

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7727525

Engineered anti-CD20 antibody fragments for in vivo targeting and therapeutics

The Regents of the University of California · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7718387

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using E

The Board of Regents of the University of Texas System · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7638130

Truncated recombinant major outer membrane protein antigen (R56) of Orientia tsutsugamushi

United States of America as represented by the Secretary of the Air Force · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7589181

Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572442

Selected antibody compositions for binding to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566540

Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7557194

Antibody materials for an IBD-associated polypeptide

The Regents of the University of California · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7510710

Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a g

The Regents of the University of Colorado · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7491802

Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer

Takeda Pharmaceutical Company Limited · Granted Tue Feb 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7468426

Oncoprotein protein kinase antibody kit

The Regents of the University of California · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7459536

HGF-SF monoclonal antibody combinations

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7342105

Antibody and use thereof

Takeda Chemical Industries Ltd. · Granted Tue Mar 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7335477

Truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi

United States of America as represented by the Secretary of the Air Force · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7332585

Bispecific single chain Fv antibody molecules and methods of use thereof

The Regents of the California University · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7285639

Antibody to telomerase reverse transcriptase

The Regents of the University of Colorado · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7256004

Variants of humanized anti-carcinoma monoclonal antibody CC49

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7247303

Selected antibody CDRs for binding to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7173112

Antibody to GALP and uses thereof

Takeda Pharmaceutical Company Limited · Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7153509

Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epit

The Regents of the University of California · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7094883

Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7094405

Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted